RSS

K pneumoniae

MAB Discovery technology is to be used for the selection and development of therapeutic antibodies against drug-resistant Klebsiella pneumoniae as part of the SPARKLE Consortium, it has been announced. more

News

The “post-antibiotic world” could soon be a reality due to a gene strain that prevents antibiotics from killing deadly bacteria researchers say more

News